The largest database of trusted experimental protocols

El4 cells

Manufactured by Merck Group

EL4 cells are a type of mouse lymphoma cell line. They are commonly used in biomedical research as a model system for various studies, including immunology, cancer biology, and drug development. EL4 cells are well-characterized and have a defined set of characteristics that make them a valuable tool for researchers.

Automatically generated - may contain errors

5 protocols using el4 cells

1

Quantifying IL17a mRNA Expression in EL4 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
EL4 cells (Sigma-Aldrich) were grown in DMEM (Gibco). At 24 h after the cells were seeded onto a 12-well plate, the cells were treated with ligands 1–3 (from 10 mM stock in DMSO) or DMSO. After 24 h, the cells were collected and RNA was isolated using a RNeasy Plus Micro Kit (Qiagen) and reverse transcribed using the iScrip cDNA biosynthesis kit (Bio-Rad). Quantitative RT–PCR was performed to analyse mRNA levels of mouse IL17a levels using SYBR green technology (Bio-Rad) on a CFX Real-Time System (Bio-Rad). Primer sequences used for IL17a:45 (link) Fw: 5′-ctccagaaggccctcagactac-3′, Rev: 5′-ctgtgtcaatgcggagggaaagct-3′ and Gapdh: Fw: 5′-ggtggacctcatggcctaca-3′, Rev: 5′-ctctcttgctcagtgtccttgct-3′. The level of IL17a mRNA expression was normalized to that of Gapdh expression. All data are expressed as the mean±s.e.m. (n=6). Statistical analysis was performed using an one-way analysis of variance comparing against the DMSO control following Dunnett post hoc test.
+ Open protocol
+ Expand
2

Generation of Murine Tumor Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
EL4 cells (catalog number: 87020408) were purchased from Sigma. Murine CD19 was transduced into EL4 via viral transduction. Phoenix-ECO (catalog number: CRL-3214) and A20 cells (TIB-208) were purchased from ATCC. A20-MHC I and MHCII knockout lines were generated using CRISPR as described (12 (link)). Tumor cells were maintained in RPMI-1640 supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine and 1% penicillin/streptomycin. Retroviral producing cell lines (Phoenix-ECO and 293 Glv9) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS, 2 mM L-glutamine and 1% penicillin/streptomycin. All cell lines are regularly tested for mycoplasma contamination.
+ Open protocol
+ Expand
3

Quantitative RT-PCR for IL-17a Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
EL4 cells (Sigma-Aldrich) were grown in DMEM (Gibco) with 10% FBS.
At 24 h after the cells were seeded onto a 12-well plate, the cells
were incubated with 10 μM compound (from 10 mM stock in DMSO)
or DMSO for 24 h and activated with phorbol 12-myristate 13-acetate
(PMA, 50 ng/mL; Sigma-Aldrich) and ionomycin (1 μg/mL; Sigma-Aldrich)
for 5 h. The cells were then collected, and RNA was isolated using
a RNeasy Mini Kit (Qiagen) and reverse transcribed using the iScript
Advanced cDNA Synthesis Kit (Bio-Rad). Quantitative RT-PCR was performed
to analyze mRNA levels of mouse IL-17a levels (in triplicate) using
SYBR green technology (Bio-Rad) on a CFX Real-Time System (Bio-Rad).
The following primer assays were purchased from Bio-Rad: IL-17a (qMmuCID0026592)
and Gapdh (qMmuCED0027497). The level of IL-17a mRNA expression was
normalized to that of Gapdh expression. The relative gene expression
was calculated by the 2–ΔΔCt (Livak)
method using the DMSO control as calibrator. (Data recorded in triplicate;
error shown is standard deviation from the mean; data are representative
of >3 repeated experiments).
+ Open protocol
+ Expand
4

Generation of Murine Tumor Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
EL4 cells (catalog number: 87020408) were purchased from Sigma. Murine CD19 was transduced into EL4 via viral transduction. Phoenix-ECO (catalog number: CRL-3214) and A20 cells (TIB-208) were purchased from ATCC. A20-MHC I and MHCII knockout lines were generated using CRISPR as described (12 (link)). Tumor cells were maintained in RPMI-1640 supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine and 1% penicillin/streptomycin. Retroviral producing cell lines (Phoenix-ECO and 293 Glv9) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS, 2 mM L-glutamine and 1% penicillin/streptomycin. All cell lines are regularly tested for mycoplasma contamination.
+ Open protocol
+ Expand
5

Quantifying IL-17A mRNA Levels in EL4 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
This assay was conducted using EL4 cells (Sigma-Aldrich), cultured in DMEM (Gibco) with 10% FBS. After seeding the cells onto a 12-well plate, they were incubated in the presence of 10 μM compound (n = 3, prepared from DMSO stock solutions) or DMSO (vehicle control) for 24 h. Subsequently, the cells were activated with phorbol 12-myristate 13-acetate (PMA, 50 ng mL−1; Sigma-Aldrich) and ionomycin (1 μg mL−1; Sigma-Aldrich) for 5 h. Following activation, the cells were collected, and RNA was isolated using a RNeasy Mini Kit (Qiagen). Reverse transcription was performed using the iScript Advanced cDNA Synthesis Kit (Bio-Rad). Quantitative RT-PCR was carried out to assess mRNA levels of mouse IL-17A (n = 3) utilizing SYBR green technology (Bio-Rad) on a CFX Real-Time System (Bio-Rad). Normalization of IL-17A mRNA expression to Gapdh expression was performed, and the relative gene expression was calculated using the 2−ΔΔCt (Livak) method with the DMSO control as the calibrator. This assay was performed in a single run (n = 3). The statistical significance levels were denoted as follows: ***p < 0.001, ****p < 0.0001, and ‘ns’ indicating non-significance in comparison to the vehicle control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!